论文部分内容阅读
过去5年中国创新微生物药物筛选与发现研究获进展,目前已拥有12万株,40万份的药用微生物菌株和20万个微生物发酵提取品,微生物产物高通量筛选模型150多个,获得了一批微生物药物先导化合物或候选物,为创新微生物药物研发奠定了良好基础。
Over the past five years, China has made progress in the screening and discovery of innovative microbial medicines. At present, it has 120,000 strains, 400,000 strains of medicinal microorganisms and 200,000 strains of microbial fermentation, and more than 150 models of high-throughput microbial products have been obtained A batch of lead compounds or candidates for microbial drugs has laid a good foundation for innovative microbial drug research and development.